Headaches: The Pulsing Enigma | Estateplanning | Vibepedia.Network

Headaches affect over 47% of the global population, with the World Health Organization (WHO) estimating that 30% of people experience tension-type headaches. The economic burden is substantial, with a study by the American Migraine Foundation revealing that migraines alone cost the US economy $36 billion annually. Despite their prevalence, headaches remain poorly understood, with debates surrounding their classification, causes, and treatment options. The International Headache Society recognizes over 150 types of headaches, including migraines, cluster headaches, and tension headaches. Research by Dr. Peter Goadsby, a leading neurologist, has shed light on the role of serotonin and calcitonin gene-related peptide (CGRP) in migraine pathophysiology. As scientists continue to unravel the mysteries of headaches, the development of effective treatments, such as CGRP inhibitors, offers hope for the millions of people worldwide who suffer from these debilitating conditions.